Atlas Trials

Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT

Clinical trial NCT00534989 · COMPLETED

Trial details

NCT number
NCT00534989
Sponsor
King Faisal Specialist Hospital & Research Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoma, Non-HodgkinHodgkin Disease
Start date
2007-09-01
Primary completion
2013-02-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.